Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Meta-analysis of 16S head and neck cancer Kenny Yeo University of Adelaide PLCO Dec 14, 2021 PLCO-879
Detection of prostate cancer using machine learning techniques: An exploratory study Laxmi Manasa Gorugantu Dakota State University PLCO Dec 13, 2021 PLCO-873
Reproducibility and external validation of epidemiological risk models for endometrial cancer Aline Talhouk Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada PLCO Dec 13, 2021 PLCO-878
Breast cancer prognosis Lee Cooper Northwestern University PLCO Dec 13, 2021 PLCOI-877
Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification Eric Li Northwestern University Feinberg School of Medicine PLCO Dec 10, 2021 PLCOI-876
Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO Hormuzd Katki NCI PLCO Dec 8, 2021 PLCO-875
Using PRS for CRC screening Ulrike Peters Fred Hutchinson Cancer Research Center PLCO Dec 8, 2021 PLCO-872
Instrumental Variable Estimation of Complier Causal Treatment Effect with Interval-Censored Data Jianguo Sun University of Missouri-Columbia PLCO Nov 30, 2021 PLCO-871
Identifying risk factors for colorectal neoplasia through machine learning Daniella Araujo Universidade Federal de Minas Gerais PLCO Nov 30, 2021 PLCO-870
Melanoma Comorbidity Clusters Vishnutheertha Kulkarni Johns Hopkins University PLCO Nov 30, 2021 PLCO-869
Multi-Organ Lesion Analysis using Deep Learning in Chest CT Le Lu Alibaba DAMO Academy NLST Nov 30, 2021 NLST-860
Lower level of education matters when it comes to compliance to lung cancer screening Akeel Alali King Abdullah International Medical Research Center’s (KAIMRC) and King Saud bin Abdulaziz university for health sciences NLST Nov 30, 2021 NLST-856
The benefits and harms of lung cancer screening in Florida Jiang Bian University of Florida Board of Trustees NLST Nov 30, 2021 NLST-857
Exploring prognostic value of tumor infiltrating lymphocytes (TILs) in multiple cancer types Shuoyu Xu Bio-totem Pte Ltd PLCO Nov 22, 2021 PLCOI-862
Combining Classifier with Bagging for endometriosis prediction. David Kilembwe Independent PLCO Nov 22, 2021 PLCO-861
Using machine learning and big data for optimizing medication prescriptions for lung cancer Jason Chang National Yunlin University of Science and Technology PLCO Nov 22, 2021 PLCO-859
Improving Measurement of Physical Activity and Sedentary Behavior Stephanie Eckman RTI International IDATA Nov 19, 2021 IDATA-50
Health economic evaluation for lung cancer screening alone or combined with screening for emphysema and coronary calcium scoring Hendrik Koffijberg University of Twente NLST Nov 15, 2021 NLST-852
Modern Statistical Models and Artificial Intelligence for Early Detection of Disease with Longitudinal Biomarker Tim Tobias Arndt Universität Augsburg PLCO Nov 15, 2021 PLCO-857
Analysis of screening technology performance and patient demographics to improve blood-based early lung cancer detection Toumy Guettouche Mercy BioAnalytics NLST Nov 15, 2021 NLST-851